Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Jongwook YuPyung Chun OhMinsu KimJeonggeun MoonYae Min ParkKyounghoon LeeSoon Yong SuhSeung Hwan HanKyunghee ByunTaehoon AhnWoong Cheol KangPublished in: PloS one (2017)
Elevated serum levels of sST2 or NT-proBNP at the time of presentation were found to predict 1-year MACCE independently and elevated serum levels of sST2 plus NT-proBNP were associated with even poorer prognosis in patients with STEMI undergoing primary PCI.
Keyphrases